Clinical Research Collaborations

Over the course of several years, Source MDx has cultivated strong working relationships with a prestigious group of medical centers - a unique element of the value the company provides to pharmaceutical and diagnostic partners. Collaborative and strategic partnerships with our pharmaceutical and diagnostic clients allow them to gain access to ongoing, Source MDx funded clinical studies within this prestigious network of medical centers. Access to this network enables Source MDx's partners to collaboratively initiate new clinical studies that address their own corporate needs and interests.

Source MDx has funded and continues to fund prospective clinical studies to develop and validate commercial molecular diagnostic tests with leading medical centers in key disease areas including:

• Brigham and Women's Hospital — Multiple Sclerosis
• Dana-Farber Cancer Institute — Bladder Cancer, Breast Cancer, Colon Cancer, Ovarian Cancer and Prostate Cancer
• Massachusetts General Hospital — Ovarian Cancer and Melanoma
• New York University Medical Center — Lung Cancer and Pulmonary Disease
• Translational Genomics Research Institute (TGEN) — Pancreatic Cancer
• Tufts Medical Center — Cardiovascular Disease, Lupus and Rheumatoid Arthritis
• University of Colorado Health Sciences Center — Melanoma and Psoriasis